mhurhangee/ep-ind-claims huggingface dataset:
A method for determining the heating value of a fuel, the fuel comprising at least one hydrocarbon including a first hydrocarbon present in the highest molar concentration, the method comprising: measuring the stoichiometric oxidation molar flow ratio of the fuel; determining the ideal molar heating value (HV m,i) from the measured stoichiometric oxidation molar flow ratio; measuring the molar concentration of the first hydrocarbon; and determining the real molar heating value (HV m,r) from the ideal molar heating value (HV m,i) and the molar concentration of the first hydrocarbon. measuring the stoichiometric oxidation molar flow ratio of the fuel; determining the ideal molar heating value (HV m,i) from the measured stoichiometric oxidation molar flow ratio; measuring the molar concentration of the first hydrocarbon; and determining the real molar heating value (HV m,r) from the ideal molar heating value (HV m,i) and the molar concentration of the first hydrocarbon.
A copolymer derived from a mixture comprising: a hydrophobic monomer having a general formula wherein, R 1 is at least one alkyl group selected from a group consisting of straight chained and branched alkyl group, having 16 to 22 carbon atoms; and R 2 is at least one group selected from a group consisting of a hydrogen atom and a methyl; and a hydrophilic monomer represented by the following general formula; wherein R 3 is one group selected from a group consisting of glyceryl group and polypropylene glycol group illustrated as -(C 3 H 6 O) n H, wherein n is an integer of 2 to 10, R 4 is at least a group selected from a group consisting of hydrogen atom and methyl.
A control system for a prosthetic device comprising: at least one sensor module adapted to receive at least one body input signal; at least one device module having at least one prosthetic control mode, the device module being in communication with the at least one sensor module; and at least one actuator of the prosthetic device configured to receive commands from the device module; wherein the device module receives at least one body input signal from the at least one sensor module and commands the at least one actuator in accordance with the at least one body input signal; and characterised in that the prosthetic control mode includes a bulk mode controlling movement of an end point of the prosthetic device within a movement envelope. at least one sensor module adapted to receive at least one body input signal; at least one device module having at least one prosthetic control mode, the device module being in communication with the at least one sensor module; and at least one actuator of the prosthetic device configured to receive commands from the device module;
A near-infrared ray absorbing synthetic resin composition containing a bipyrrolo isoquinoline compound represented by the following general formula and a synthetic resin: wherein R 1 and R 2 may be identical with or different from each other, and each represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 20 carbon atoms optionally having substituents, an alkoxy group having 1 to 20 carbon atoms optionally having substituents, an aryl group having 6 to 20 carbon atoms optionally having substituents, an arylalkyl group having 7 to 20 carbon atoms optionally having substituents, or a cycloalkyl group having 5 to 12 carbon atoms optionally having substituents, wherein the content of the bipyrrolo isoquinoline compound represented by the general formula is 0.001 to 5 parts by mass with respect to 100 parts by mass of the synthetic resin.
A device for joining overlapped end portions (71, 72) of a rubber member with one of the end portions (71,72) placing on the other of the end portions (71, 72) of the rubber member, the device comprising: a pressing roll in the form of a disk-shaped roll having a rolling surface inclined toward a rotation center and rotating about an inclined shaft, the inclined shaft being disposed inclined by a predetermined inclination angle θ 2 with respect to a surface of the overlapped upper end portion of the rubber member, so that when the disk-shaped roll is moved while being pressed against the overlapped upper end portion of the rubber member, the disk-shaped roll abuts against the overlapped upper end portion of the rubber member along a line, and the inclined shaft being inclined by a predetermined inclination angle θ 1 in a plan view toward a joining end with respect to a travel direction of the pressing roll to apply a shearing force to the surface of the overlapped upper end portion of the rubber member in a direction perpendicular to the line; means for pressing a rolling surface of the pressing roll against the overlapped upper end portion of the rubber member; and a moving unit for rolling the rolling surface of the pressing roll while pressing the rolling surface thereof against the upper end portion of the rubber member. a pressing roll in the form of a disk-shaped roll having a rolling surface inclined toward a rotation center and rotating about an inclined shaft, the inclined shaft being disposed inclined by a predetermined inclination angle θ 2 with respect to a surface of the overlapped upper end portion of the rubber member, so that when the disk-shaped roll is moved while being pressed against the overlapped upper end portion of the rubber member, the disk-shaped roll abuts against the overlapped upper end portion of the rubber member along a line, and the inclined shaft being inclined by a predetermined inclination angle θ 1 in a plan view toward a joining end with respect to a travel direction of the pressing roll to apply a shearing force to the surface of the overlapped upper end portion of the rubber member in a direction perpendicular to the line; means for pressing a rolling surface of the pressing roll against the overlapped upper end portion of the rubber member; and a moving unit for rolling the rolling surface of the pressing roll while pressing the rolling surface thereof against the upper end portion of the rubber member.
System comprising a double-sided adhesive sheet for image display device to bond any two adherends selected from a surface protective panel, a touch panel, and an image display panel, the system further comprising at least one of the adherends, wherein at least one of the adherends has a stepped portion (2b, 4a) on an adhesion surface to adhere to the double-sided adhesive sheet; and a surface shape of a bonding surface of the double-sided adhesive sheet to adhere to the adhesion surface is shaped in accordance with a surface shape of the adhesion surface.
A hydroxy fatty acid and/or an oxo fatty acid for use in the prophylaxis or treatment of at least one condition selected from the group consisting of obesity, diabetes, hyperlipidemia, and fatty liver, wherein the hydroxy fatty acid is at least one compound selected from the group consisting of 10-hydroxy-cis-12-octadecenoic acid, 10-hydroxy-cis-12,cis-15-octadecadienoic acid, 10-hydroxy-cis-6,cis-12-octadecadienoic acid, 10-hydroxy-cis-6,cis-12,cis-15-octadecatrienoic acid, 10,12-dihydroxyoctadecanoic acid, 10-hydroxy-cis-15-octadecenoic acid, 10-hydroxy-cis-6-octadecenoic acid, 10-hydroxy-cis-6,cis-15-octadecadienoic acid, 10-hydroxy-trans-11-octadecenoic acid, 10-hydroxy-trans-11,cis-15-octadecadienoic acid, 10-hydroxy-cis-6,trans-11-octadecadienoic acid, and 10-hydroxy-cis-6,trans-11,cis-15-octadecatrienoic acid, and the oxo fatty acid is at least one compound selected from the group consisting of 10-oxo-cis-12-octadecenoic acid, 10-oxo-cis-12,cis-15-octadecadienoic acid, 10-oxo-cis-6,cis-12-octadecadienoic acid, 10-oxo-cis-6,cis-12,cis-15-octadecatrienoic acid, 10-oxooctadecanoic acid, 10-oxo-cis-6-octadecenoic acid, 10-oxo-cis-15-octadecenoic acid, 10-oxo-cis-6,cis-15-octadecadienoic acid, 12-oxooctadecanoic acid, 10-oxo-trans-11-octadecenoic acid, 10-oxo-cis-6,trans-11-octadecadienoic acid, 10-oxo-trans-11,cis-15-octadecadienoic acid, 10-oxo-cis-6,trans-11,cis-15-octadecatrienoic acid, and 12-oxo-cis-9-octadecenoic acid.
A terminal apparatus comprising: a measurement unit configured to measure at least one of a latency when a wireless signal is transmitted to a base station and a jitter of the wireless signal; a data processing unit configured to generate information including a result of the measurement; and a wireless signal processing unit configured to transmit the information to the base station, characterized in that the wireless signal processing unit controls transmission of the wireless signal in accordance with an access category of the wireless signal classified in accordance with data included in the wireless signal, and the measurement unit measures at least one of the latency and the jitter for the access category. a measurement unit configured to measure at least one of a latency when a wireless signal is transmitted to a base station and a jitter of the wireless signal; a data processing unit configured to generate information including a result of the measurement; and a wireless signal processing unit configured to transmit the information to the base station, characterized in that the wireless signal processing unit controls transmission of the wireless signal in accordance with an access category of the wireless signal classified in accordance with data included in the wireless signal, and the measurement unit measures at least one of the latency and the jitter for the access category.
A cup arranged to be inserted into a bone cavity to form a socket component of a prosthetic ball and socket joint, the cup comprising a substrate having a convex surface: wherein the convex surface of the substrate has a first area and a series of interruptions in the first area, at least the first area being treated such that osseointegration is promoted to a different extent to the interruptions; wherein the interruptions extend across portions of the convex surface of the cup at predetermined angles relative to a rim of the cup to form a series of alignment marks to assist alignment of the cup relative to a bone; and wherein the cup is arranged to be at least partially inserted into a bone cavity such that the alignment marks indicate portions of the cup which are intended to protrude from the bone cavity when the cup is tilted within the bone cavity. wherein the convex surface of the substrate has a first area and a series of interruptions in the first area, at least the first area being treated such that osseointegration is promoted to a different extent to the interruptions; wherein the interruptions extend across portions of the convex surface of the cup at predetermined angles relative to a rim of the cup to form a series of alignment marks to assist alignment of the cup relative to a bone; and wherein the cup is arranged to be at least partially inserted into a bone cavity such that the alignment marks indicate portions of the cup which are intended to protrude from the bone cavity when the cup is tilted within the bone cavity.
A coffee extraction method with a coffee machine comprising an infusion circuit at least including a water tank or a connection to a water source, a supply pump, an electric heater and an infusion unit having an infusion chamber where a dose of coffee powder can be positioned, connected in sequence,wherein said machine stores a plurality of selectable extraction cycles each including in sequence an infusion circuit heat regulation step, a step of introducing said dose into said infusion chamber, and a step of extracting coffee having an initial coffee extraction temperature value (Ti), and in that at least one extraction cycle envisages the extraction step with an initial extraction temperature value (Ti) equal to room temperature and with said electric heater deactivated, characterized in that, after acquiring a selection of a coffee extraction cycle, the coffee machine detects the value of a temperature along the infusion circuit, compares said detected temperature value with the initial extraction temperature value (Ti) of the selected extraction cycle, and performs the heat regulation step by activating the supply pump to generate a heat regulation water flow in the absence of said dose of coffee in said infusion chamber until said detected temperature value achieves said initial extraction temperature value (Ti) of the selected extraction cycle.
A retractable key assembly for a handheld device, comprising: one or more L-shaped key structures each having a first member configured to receive an input keystroke and a second member substantially orthogonal to the first member; and a frame configured to receive the one or more L-shaped key structures, the frame having a wall aligned with the second member of the key structure, with the wall further comprising a switch for each of the one or more L-shaped key structures on an inner surface of the wall, wherein each switch is arranged to engage with an actuator on the second member of the corresponding key structure such that depression of a given key structure causes the actuator of the second member of the key structure to engage the switch of the wall, wherein each of the one or more L-shaped key structures pivots about a point proximate a junction between the first member and the second member, and wherein the frame is rotatable with respect to a housing of the handheld device. one or more L-shaped key structures each having a first member configured to receive an input keystroke and a second member substantially orthogonal to the first member; and a frame configured to receive the one or more L-shaped key structures, the frame having a wall aligned with the second member of the key structure, with the wall further comprising a switch for each of the one or more L-shaped key structures on an inner surface of the wall, wherein each switch is arranged to engage with an actuator on the second member of the corresponding key structure such that depression of a given key structure causes the actuator of the second member of the key structure to engage the switch of the wall,
An antibody having specificity to nectin-4 and having - a heavy chain comprising i) a H-CDR1 having at least 90% of identity with the H-CDR1 of N41mab, ii) a H-CDR2 having at least 90% of identity with the H-CDR2 of N41mab and iii) a H-CDR3 having at least 90% of identity with the H-CDR3 of N41mab and - a light chain comprising i) a L-CDR1 having at least 90% of identity with the L-CDR1 of N41mab, ii) a L-CDR2 having at least 90% of identity with the L-CDR2 of N41mab and iii) a L-CDR3 having at least 90% of identity with the L-CDR3 of N41mab wherein - the H-CDR1 of N41mab is defined by the sequence ranging from the amino acid residue at position 31 to the amino acid residue at position 35 in SEQ ID NO:1, - the H-CDR2 of N41mab is defined by the sequence ranging from the amino acid residue at position 50 to the amino acid residue at position 65 in SEQ ID NO:1, - the H-CDR3 of N41mab is defined by the sequence ranging from the amino acid residue at position 98 to the amino acid residue at position 105 in SEQ ID NO:1, - the L-CDR1 of N41mab is defined by the sequence ranging from the amino acid residue at position 24 to the amino acid residue at position 34 in SEQ ID NO:2, - the L-CDR2 of N41mab is defined by the sequence ranging from the amino acid residue at position 50 to the amino acid residue at position 56 in SEQ ID NO:2., and - the L-CDR3 of N41mab is defined by the sequence ranging from the amino acid residue at position 89 to the amino acid residue at position 96 in SEQ ID NO:2. - a heavy chain comprising i) a H-CDR1 having at least 90% of identity with the H-CDR1 of N41mab, ii) a H-CDR2 having at least 90% of identity with the H-CDR2 of N41mab and iii) a H-CDR3 having at least 90% of identity with the H-CDR3 of N41mab and - a light chain comprising i) a L-CDR1 having at least 90% of identity with the L-CDR1 of N41mab, ii) a L-CDR2 having at least 90% of identity with the L-CDR2 of N41mab and iii) a L-CDR3 having at least 90% of identity with the L-CDR3 of N41mab - the H-CDR1 of N41mab is defined by the sequence ranging from the amino acid residue at position 31 to the amino acid residue at position 35 in SEQ ID NO:1, - the H-CDR2 of N41mab is defined by the sequence ranging from the amino acid residue at position 50 to the amino acid residue at position 65 in SEQ ID NO:1, - the H-CDR3 of N41mab is defined by the sequence ranging from the amino acid residue at position 98 to the amino acid residue at position 105 in SEQ ID NO:1, - the L-CDR1 of N41mab is defined by the sequence ranging from the amino acid residue at position 24 to the amino acid residue at position 34 in SEQ ID NO:2, - the L-CDR2 of N41mab is defined by the sequence ranging from the amino acid residue at position 50 to the amino acid residue at position 56 in SEQ ID NO:2., and - the L-CDR3 of N41mab is defined by the sequence ranging from the amino acid residue at position 89 to the amino acid residue at position 96 in SEQ ID NO:2.
A method (1300-a) for wireless communications comprising: interpreting, by a user equipment, UE, a first set of received data; and determining, by the UE utilizing the first set of received data, a bandwidth information associated with a flexible bandwidth carrier, wherein the bandwidth information comprises a bandwidth scaling factor and wherein the determining the bandwidth information associated with the flexible bandwidth carrier includes utilizing a sequence of bandwidth scaling factors to determine the bandwidth scaling factor to be used in acquiring and decoding information conveyed by the flexible bandwidth carrier, the flexible bandwidth carrier being generated through dilating a frame length or scaling down a chip rate of the flexible bandwidth carrier with respect to a frame length or a chip rate of a normal bandwidth carrier, respectively, wherein the bandwidth information is included in a second set of received data different from the first set of received data. interpreting, by a user equipment, UE, a first set of received data; and determining, by the UE utilizing the first set of received data, a bandwidth information associated with a flexible bandwidth carrier, wherein the bandwidth information comprises a bandwidth scaling factor and wherein the determining the bandwidth information associated with the flexible bandwidth carrier includes utilizing a sequence of bandwidth scaling factors to determine the bandwidth scaling factor to be used in acquiring and decoding information conveyed by the flexible bandwidth carrier, the flexible bandwidth carrier being generated through dilating a frame length or scaling down a chip rate of the flexible bandwidth carrier with respect to a frame length or a chip rate of a normal bandwidth carrier, respectively, wherein the bandwidth information is included in a second set of received data different from the first set of received data.
Method for supplying feed for rearing insect larvae, the method comprising the steps of (o) supplying feed to a container using a coarse feed supplying means, (i) determining at a determining means the amount of feed in or added to the container, wherein the determining means comprises at least one weighing station, (ii) calculating the amount of feed necessary to bring the total amount of feed in the container to a predetermined amount of feed, and (iii) supplying feed to the container in the amount calculated in step (ii) using a fine feed supplying means (3, 4), wherein the method further comprises transporting the container by a transport means from the coarse feed supplying means to the fine feed supplying means (3, 4), wherein the determining means is integrated into the transport means. (i) determining at a determining means the amount of feed in or added to the container, wherein the determining means comprises at least one weighing station, (ii) calculating the amount of feed necessary to bring the total amount of feed in the container to a predetermined amount of feed, and (iii) supplying feed to the container in the amount calculated in step (ii) using a fine feed supplying means (3, 4),
A method for manufacturing a microlens, comprising: providing a carrier, applying a resist layer on the carrier, forming an opening with an overhanging or re-entrant sidewall in the resist layer, the carrier being uncovered in the opening, depositing a lens material, thus forming a lens on the carrier in the opening, and removing the resist layer, characterized in that the overhanging or re-entrant sidewall is formed to comprise at least one step, which provides different widths (w 1, w 2, w 3, w 4) of the opening in regions of different depths (d 1, d 2, d 3, d 4) of the resist layer. providing a carrier, applying a resist layer on the carrier, forming an opening with an overhanging or re-entrant sidewall in the resist layer, the carrier being uncovered in the opening, depositing a lens material, thus forming a lens on the carrier in the opening, and removing the resist layer, characterized in that the overhanging or re-entrant sidewall is formed to comprise at least one step, which provides different widths (w 1, w 2, w 3, w 4) of the opening in regions of different depths (d 1, d 2, d 3, d 4) of the resist layer.
An air-breathing engine for a hypersonic vehicle, the engine comprising: a converging inlet having a fixed cowling having a first cross-sectional area and a throat in fluid communication with the cowling and having a second cross-sectional area, smaller than the first cross-sectional area; and a flow restrictor having a third cross-sectional area that is smaller than the first cross-sectional area and movable between a stowed position and a fully deployed position characterized in that a consistent gap is formed between a periphery of the flow restrictor and an inner surface of the cowling with the flow restrictor in the fully deployed position, and a difference between the first cross-sectional area of the cowling and the third cross-sectional area of the flow restrictor is approximately equal to the second cross-sectional area of the throat. a converging inlet having a fixed cowling having a first cross-sectional area and a throat in fluid communication with the cowling and having a second cross-sectional area, smaller than the first cross-sectional area; and a flow restrictor having a third cross-sectional area that is smaller than the first cross-sectional area and movable between a stowed position and a fully deployed position characterized in that a consistent gap is formed between a periphery of the flow restrictor and an inner surface of the cowling with the flow restrictor in the fully deployed position, and a difference between the first cross-sectional area of the cowling and the third cross-sectional area of the flow restrictor is approximately equal to the second cross-sectional area of the throat.
A method of obtaining human arterial endothelial cells, the method comprising culturing human mesodermal cells in a serum-free, albumin-free, chemically defined culture medium that is substantially free of insulin and comprises a fibroblast growth factor, a vascular endothelial growth factor (VEGF), and at least one of a Notch agonist, a TGF-beta inhibitor, and an inhibitor of inositol monophosphatase, whereby a cell population comprising at least 80% human arterial endothelial cells is obtained, wherein arterial endothelial cells of the population express Ephrin B2 (EFNB2), neuropilin1 (NRP-1), Delta-like 4, CXCR4/CD184, Gap Junction Protein Alpha-4, and Heyl, and one or more markers selected from the group consisting of Jagged-1, Notch1, and Notch4.